Authors


Matthias Arnold, Dr Oec Publ

Latest:

Cost-effectiveness of Case Management: A Systematic Review

This systematic review found that studies of case management interventions have adequate quality and, in many cases, show cost-effective or even cost-saving results.


Mark Newsom, MS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Janke Mains-Mason, MPH

Latest:

Empiric Segmentation of High-risk Patients: A Structured Literature Review

Data-driven segmentation of high-risk patient populations may inform health system interventions, but results are dependent on the data sources and methods applied.


Riccardo Lemini, MD

Latest:

Impact of Travel Distance on Quality Outcomes in Colorectal Cancer

This study identified characteristics of patients with colorectal cancer who traveled farther for surgery and found that those who traveled tended to stay longer at the hospital.


Hank Schlissberg

Latest:

Contributor: Increasing Data Transparency in Pharmacy

Patients and prescribers should be able to see the total bottom-line cost of medications along with the clinical support for why they are using them.


Christian Johnson, MPH

Latest:

Integrating Third-Party Apps With Electronic Health Records to Support COVID-19 Response

This study observed a rapid increase in the integration of telehealth- and COVID-19–related apps with electronic health records during the COVID-19 pandemic.


Christian Ruff, MD | image credit: physiciandirectory.brighamandwomens.org
Christian Ruff, MD

Latest:

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.


Ramanjot Kaur, BSc

Latest:

Covishield India: Demystifying Myths Through an Early Multicenter Safety Study

This was a multicenter study carried out in India to study the adverse and systemic effects of the indigenously developed Covishield vaccine.


Christopher G. Parkin, MS

Latest:

The Role of Advanced Technologies in Improving Diabetes Outcomes

This article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.


Jacqueline Matian, PharmD

Latest:

Medication Persistence and Its Impact on Type 2 Diabetes

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.


Saranya Ramakrishnan, MPH

Latest:

A Kidney Diagnostic’s Impact on Physician Decision-making in Diabetic Kidney Disease

The KidneyIntelX test would affect primary care physician (PCP) decision-making, and PCPs would use the results of KidneyIntelX more than albuminuria and estimated glomerular filtration rate when making decisions about diabetic kidney disease management.



Mark Adelsberg, MPP

Latest:

Sacubitril/Valsartan in Medicare Alternative Payment Models

Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.


Amol Gupta, MBBS

Latest:

AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting

Using Plan-Do-Study-Act cycles, the studied intervention reduced hospital inpatient telemetry time by 51.25% while increasing American Heart Association (AHA) guideline–based usage.


Donald Trigg

Latest:

Contributor: 3 Key Questions for the Biden Administration and the 117th Congress Coming Out of the COVID-19 Crisis

The incoming Biden administration will be challenged to address flex capacity, the supply chain, and real-time data as we transition from coronavirus disease 2019 (COVID-19) response to durable recovery.


Courtney Harold Van Houtven, PhD, MSc

Latest:

Predictors of Discharge From the VA Caregiver Support Program

The year of application predicts discharge from the Department of Veterans Affairs (VA) caregiver program. Unexpected, disallowed criteria also predict discharge, with significant others facing higher discharge risk than spouses.


Sara Rogers, PharmD

Latest:

Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans

This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.


Chanhyun Park, PhD

Latest:

Inability to Access Health Care Due to COVID-19 Among Medicare Beneficiaries

Up to one-fifth of Medicare beneficiaries were unable to access health care due to the COVID-19 pandemic in 2020.


Galo M. Sanchez Palacios, MD

Latest:

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.


Faiyaz Syed, MD, MPH

Latest:

Barriers and Facilitators to Managing Social Care in the Digital Era Among Michigan Health Centers

There is widespread interest in understanding the role of health care in meeting social needs. This study examines community-wide activities, resources, and information technology used to manage social care.


Cynthia Moreau, PharmD, BCACP, CPh

Latest:

Provider Perceptions of Pharmacists in Primary Care–Based Accountable Care Organizations

In this article, the authors describe their experiences addressing provider perceptions and methods to overcome several challenges to clinical pharmacist integration in primary care–based accountable care organizations.


Robert M. Rifkin, MD, FACP

Latest:

Navigating Adverse Events in Bispecific Antibody Therapies: Infection Prevention and Management

Robert M. Rifkin, MD, FACP, discusses how the MagnetisMM-3 update at the 66th American Society of Hematology Annual Meeting and Exposition sheds light on elranatamab’s role in relapsed/refractory multiple myeloma while panelists discuss how emerging data on bispecific antibodies and combination strategies could shape treatment timing and improve outcomes, especially in heavily pretreated patients.


Amy McMichael, MD

Latest:

Discussing the Pathophysiology of Alopecia Areata

Panelists discuss how alopecia areata (AA) is a chronic autoimmune disease characterized by inflammation that attacks hair follicles, leading to hair loss and varying disease progression.


Abigail Wiser, BS

Latest:

Addressing the Opioid Crisis

The authors highlight the diversity of multiagency electronic data-sharing approaches and present a case study addressing the opioid crisis


Hyun Kyung Chun, PharmD

Latest:

Hospital Outcomes of Male Breast Cancer in the United States

This is the first study to estimate the hospital lengths of stay and costs of male breast cancer at the US population level.


Soleyah Groves, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Lisa Engel, MA, BA

Latest:

Implementing Multistate Behavioral Health Pay-for-Performance Initiatives in Medicaid Managed Care

The authors describe a pay-for-performance initiative targeting behavioral health providers, which was introduced by a large Medicaid managed care organization across multiple states.


Rita de Cassia Castro, MD

Latest:

Baloxavir vs Oseltamivir: Reduced Utilization and Costs in Influenza

Baloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.


Stephen Schondelmeyer, PharmD, PhD

Latest:

Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.


Jean Feng, PhD

Latest:

Reducing Readmissions in the Safety Net Through AI and Automation

Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while improving clinical and equity outcomes.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo